Follow US:
Scientists identify two compounds that could benefit people living with multiple sclerosis
Study may explain why some people living with multiple sclerosis experience epileptic seizures
STOP COVID-19 CA showed how researchers and communities can work together to tackle health disparities
UCR Health’s Dr. Alia Tuqan shares tips on staying healthy, active, and connected as we age
Researchers call for extended care and monitoring after pediatric head injuries
International team to study immune defenses against Crimean-Congo hemorrhagic fever virus
NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer
UC Riverside psychiatrists call for reform to protect families from trauma
Strategy could greatly benefit underserved populations lacking primary care and health insurance
IPV affects college students at high rates, with Latina students being at heightened risk
UC Riverside study highlights need for protective measures for agricultural workers
UCR medical students gain valuable experience attending to patients and medical issues
UC Riverside study on how Toxoplasma gondii manipulates brain cells lays groundwork for future clinical research and therapies
UC Riverside study could lead to new treatments addressing multiple sclerosis
Researchers identify gene mutation that disrupts iron absorption, helping explain patients’ persistent anemia
UCR Health announced on Tuesday, June 3, a major expansion of its clinical footprint, with a signed letter of intent targeting an initial 21 acres in Riverside at the intersection of Valley Springs Parkway and Gateway Drive. The vision for the site will include an outpatient diagnostic center and possible...
UC Riverside biomedical scientists discuss the causes, consequences, and public health challenges of measles
UC Riverside scholars highlight how proposed federal reductions could strip coverage and care from millions
UC Riverside-led study offers a framework for involving non-maternal caregivers in public health initiatives
The Trump administration has proposed terminating a $56 million annual grant program that distributes naloxone, also known by the brand name Narcan, and trains emergency responders to administer the drug in the case of opioid overdoses. It's believed to have saved hundreds of thousands of lives. We asked two UCR...
